Effect of the beta-receptor blocking agent Visken on the action of coumarin.
In a double-blind study, the influence of Visken on the effect of anticoagulant therapy with Marcoumar was examined. In comparison to a placebo group, neither any influence on the Quick time, nor any increased tendency to haemorrhage bleeding could be detected.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000367:Age Factors; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D001157:Arterial Occlusive Diseases / Q000188:drug therapy; D001777:Blood Coagulation / Q000187:drug effects*; D001778:Blood Coagulation Disorders / Q000188:drug therapy; D001827:Body Height; D001835:Body Weight; D003327:Coronary Disease / Q000188:drug therapy; D003374:Coumarins / Q000494:pharmacology*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D010919:Placebos; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D000925:Anticoagulants; D003374:Coumarins; D010919:Placebos